Search
Now showing items 1-6 of 6
Feline CTLA-4 nucleic acid and polypeptides
(United States. Patent and Trademark Office, 2010-06-29)
The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
Compositions and methods of enhancing immune responses to Eimeria
(United States. Patent and Trademark Office, 2015-02-17)
Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods ...
Compositions and methods of enhancing immune responses
(United States. Patent and Trademark Office, 2013-12-10)
Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
Feline CD86 polypeptides and nucleic acids
(United States. Patent and Trademark Office, 2011-12-06)
The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
Compositions, organisms, systems, and methods for expressing a gene product in plants using SCBV expression control sequences operable in monocots and dicots
(United States. Patent and Trademark Office, 2014-04-29)
The present disclosure relates, in some embodiments, to compositions, organisms, systems, and methods for expressing a gene product in a plant using a expression control sequence (ECS) operable in monocots and/or dicots. ...
Cancer treatment targeting non-coding RNA overexpression
(United States. Patent and Trademark Office, 2015-02-17)
Provided herein are methods directed to modulating the pro-oncogenic effects of noncoding RNAs (ncRNAs) through their interactions with specificity protein transcription factors (SpTFs). In one aspect, the disclosure ...